William J Peters is CFO, EVP & TREASURER of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 94,103 shares of AMPH, which is worth approximately $2.99 Million. The most recent transaction as insider was on Apr 17, 2023, when has been sold 5,632 shares (Common Stock) at a price of $13.35 per share, resulting in proceeds of $75,187. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 94.1K
0% 3M change
7.16% 12M change
Total Value Held $2.99 Million

WILLIAM J PETERS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 17 2023
BUY
Exercise of conversion of derivative security
$75,187 $13.35 p/Share
5,632 Added 4.84%
110,780 Common Stock
Apr 13 2023
SELL
Open market or private sale
$206,159 $42.35 p/Share
4,868 Reduced 4.42%
105,148 Common Stock
Apr 13 2023
BUY
Exercise of conversion of derivative security
$64,987 $13.35 p/Share
4,868 Added 4.24%
110,016 Common Stock
Apr 10 2023
SELL
Open market or private sale
$404,791 $40.35 p/Share
10,032 Reduced 8.71%
105,148 Common Stock
Apr 10 2023
BUY
Exercise of conversion of derivative security
$133,927 $13.35 p/Share
10,032 Added 8.01%
115,180 Common Stock
Mar 17 2023
SELL
Payment of exercise price or tax liability
$151,038 $36.29 p/Share
4,162 Reduced 3.81%
105,148 Common Stock
Mar 16 2023
SELL
Payment of exercise price or tax liability
$187,812 $37.6 p/Share
4,995 Reduced 4.37%
109,310 Common Stock
Mar 15 2023
SELL
Open market or private sale
$465,429 $36.43 p/Share
12,776 Reduced 9.74%
118,451 Common Stock
Mar 15 2023
SELL
Payment of exercise price or tax liability
$152,738 $36.84 p/Share
4,146 Reduced 3.5%
114,305 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
$99,985 $14.95 p/Share
6,688 Added 4.85%
131,227 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
23,925 Added 16.12%
124,539 Common Stock
Mar 01 2023
SELL
Open market or private sale
$398,685 $36.33 p/Share
10,974 Reduced 9.83%
100,614 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
$124,335 $11.33 p/Share
10,974 Added 8.95%
111,588 Common Stock
Aug 09 2022
SELL
Open market or private sale
$383,500 $38.35 p/Share
10,000 Reduced 9.05%
100,480 Common Stock
Aug 09 2022
BUY
Exercise of conversion of derivative security
$133,500 $13.35 p/Share
10,000 Added 8.3%
110,480 Common Stock
Jun 30 2022
SELL
Open market or private sale
$642,591 $34.95 p/Share
18,386 Reduced 15.47%
100,480 Common Stock
Jun 30 2022
BUY
Exercise of conversion of derivative security
$274,871 $14.95 p/Share
18,386 Added 13.4%
118,866 Common Stock
Jun 17 2022
SELL
Open market or private sale
$176,660 $32.05 p/Share
5,512 Reduced 5.2%
100,480 Common Stock
May 19 2022
SELL
Payment of exercise price or tax liability
$12,739 $33.7 p/Share
378 Reduced 0.36%
104,609 Common Stock
Mar 17 2022
SELL
Payment of exercise price or tax liability
$142,257 $34.18 p/Share
4,162 Reduced 3.81%
104,987 Common Stock
Mar 16 2022
SELL
Open market or private sale
$1,734,035 $34.15 p/Share
50,777 Reduced 30.79%
114,144 Common Stock
Mar 16 2022
SELL
Payment of exercise price or tax liability
$170,929 $34.22 p/Share
4,995 Reduced 4.38%
109,149 Common Stock
Mar 16 2022
BUY
Exercise of conversion of derivative security
$731,189 $14.4 p/Share
50,777 Added 23.54%
164,921 Common Stock
Mar 15 2022
SELL
Payment of exercise price or tax liability
$208,058 $34.74 p/Share
5,989 Reduced 4.99%
114,144 Common Stock
Mar 15 2022
SELL
Open market or private sale
$272,234 $34.46 p/Share
7,900 Reduced 7.45%
98,142 Common Stock
WJP

William J Peters

CFO, EVP & TREASURER
Rancho Cucamonga, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH